Literature DB >> 7657275

Rapid and efficient gene transfer in Human hepatocytes by herpes viral vectors.

Y Fong1, H J Federoff, M Brownlee, D Blumberg, L H Blumgart, M F Brennan.   

Abstract

Retroviral vectors have been widely studied as vehicles for hepatocyte gene therapy, but they are limited by an inability to infect nondividing cells and the need for prolonged cell culture. Two replication deficient herpes simplex viral vectors (HSV) were constructed with the marker genes lac-Z/beta-galactosidase (HSVlac) or human-growth hormone (HSVhGH) to determine the efficiency of HSV gene transfer into adult human hepatocytes. Hepatocytes were isolated by collagenase perfusions and density centrifugation from liver wedge biopsy specimens obtained from six patients. After exposure to HSV (0, 50,000 and 500,000 viral particles/ 10(6) hepatocytes) for 20 minutes, 1 hour, or 2 hours, the hepatocytes were washed and placed in culture. Hepatocytes transduced with HSVlac were fixed at 24 hours and histochemically stained with X-gal, and media from HSVhgh-transduced cells were assayed at 48 hours by radioimmunoassay for hGH. After a 20-minute exposure at a multiplicity of infection of 0.5 (1 viral particle per 2 hepatocytes), greater than 35% of the hepatocytes expressed the lac-Z gene ( > 70% efficiency). hGH was also detected in the media from HSVhGH-transduced cells, showing that proteins coded for by foreign cells are not only expressed by transduced cells but are also secreted. Isolated liver perfusions using HSVlac were also performed in Fischer rats. A 20-minute isolated perfusion using 5 x 10(6) viral particles resulted in expression of the beta-galactosidase gene in the rodent livers 72 hours later without histological signs of tissue injury.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657275

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.

Authors:  M D'Angelica; C Tung; P Allen; M Halterman; K Delman; T Delohery; D Klimstra; M Brownlee; H Federoff; Y Fong
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

2.  Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.

Authors:  C Fraefel; D R Jacoby; C Lage; H Hilderbrand; J Y Chou; F W Alt; X O Breakefield; J A Majzoub
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

3.  Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model.

Authors:  W R Jarnagin; K Delman; D Kooby; S Mastorides; J Zager; M F Brennan; L H Blumgart; H Federoff; Y Fong
Journal:  Ann Surg       Date:  2000-05       Impact factor: 12.969

4.  Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury.

Authors:  Hong Liang Guo; Darren Wolfe; Michael W Epperly; Shaohua Huang; Kaihong Liu; Joseph C Glorioso; Joel Greenberger; David Blumberg
Journal:  J Gastrointest Surg       Date:  2003-02       Impact factor: 3.452

5.  Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer.

Authors:  Keith A Delman; Jonathan S Zager; Joseph J Bennett; Sandeep Malhotra; Michael I Ebright; Priscilla F McAuliffe; Marc W Halterman; Howard J Federoff; Yuman Fong
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

6.  G207, modified herpes simplex virus type 1, kills human pancreatic cancer cells in vitro.

Authors:  J H Lee; H J Federoff; L O Schoeniger
Journal:  J Gastrointest Surg       Date:  1999 Mar-Apr       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.